Guardant Health (GH) director’s stake rises on RSU vesting
Rhea-AI Filing Summary
Guardant Health, Inc. (GH) director Manuel Hidalgo Medina reported the vesting and conversion of restricted stock units into common stock. On August 17, 2026, 232 restricted stock units were converted into 232 shares of common stock at an exercise price of $0.00 per share. Following these transactions, he held 4,788 shares of common stock directly and 5,337 restricted stock units, which continue to vest under an award granted on July 17, 2024.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 232 shares
Net Buy
2 txns
Insider
Hidalgo Medina Manuel
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 232 | $0.00 | $0.00 |
| Exercise | Common Stock | 232 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 5,337 shares (Direct);
Common Stock — 4,788 shares (Direct)
Footnotes (2)
- F1. The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
- F2. Not applicable for Restricted Stock Units.
Key Figures
RSUs Converted: 232 shares
Exercise Price: $0.00 per share
Common Shares After Transaction: 4,788 shares
+4 more
7 metrics
RSUs Converted
232 shares
Restricted stock units converted into common stock on August 17, 2026
Exercise Price
$0.00 per share
Conversion of restricted stock units into common stock
Common Shares After Transaction
4,788 shares
Directly held by Manuel Hidalgo Medina after August 17, 2026 transaction
RSUs After Transaction
5,337 units
Restricted stock units remaining following reported vesting and conversion
RSU Grant Date
July 17, 2024
Grant date of the restricted stock unit award subject to four-year vesting
Initial Vesting Portion
25%
Portion of RSU award that vested on July 17, 2025
Remaining Vesting Period
3 years
Remaining RSUs vest monthly over three years after July 17, 2025
Key Terms
Restricted Stock Units, derivative security, vesting
3 terms
Restricted Stock Units financial
"The restricted stock unit award granted on July 17, 2024 vests over a four-year period"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_action is described as derivative exercise/conversion of a derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"25% of the shares subject to such award vested on July 17, 2025"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did GH director Manuel Hidalgo Medina report in this Form 4?
He reported the conversion of 232 restricted stock units into 232 shares of Guardant Health common stock on August 17, 2026, at an exercise price of $0.00 per share, reflecting a vesting event from a prior equity award.
How many restricted stock units in GH does Manuel Hidalgo Medina still hold?
Following the reported vesting, he holds 5,337 restricted stock units in Guardant Health. These RSUs are part of an equity award that continues to vest over time according to its original four-year vesting schedule.
What is the vesting schedule of Manuel Hidalgo Medina’s Guardant Health RSU award?
The RSU award granted on July 17, 2024 vests over four years: 25% vested on July 17, 2025, and the remaining 75% vests in equal monthly installments over the subsequent three years, subject to continued service.
Was a Rule 10b5-1 trading plan used for Manuel Hidalgo Medina’s GH transactions?
The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirmative. The reported transactions stem from RSU vesting and conversion, not from a disclosed pre-arranged trading plan under Rule 10b5-1.
AI-generated analysis. How Rhea-AI works. Not financial advice.
